Hansa Biopharma — Major Shareholding Notification 2020

Aug 31, 2020

Issuer Hansa Biopharma AB

Holder

Nexttobe AB

Instrument

Instrument	Ordinary shares SE0002148817
Before the transaction
Shares	5,755,379
Voting rights	5,755,379
Transaction
Reason for major shareholding notification Sell
Date	31/08/2020
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	2,155,379
Directly held voting rights	2,155,379
Indirectly held voting rights	0
Percentage
Directly held shares	4.69634 %
Directly held voting rights	4.831 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.831 %	2,155,379
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	4.831 %	2,155,379
Group total holdings
Voting rights 2,155,379
Percentage of voting rights 4.831
Published
31/08/2020 11:37

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25